Demegestone

Demegestone
IUPAC name (8S,13S,14S,17S)-17-acetyl-13,17-dimethyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one
Other names RU 2453; 17-Methyl-19-norpregna-4,9-diene-3,20-dione
Identifiers
CAS number	10116-22-0
PubChem	93057
KEGG	D07223 Y
Jmol-3D images	Image 1
SMILES CC(=O)[C@]1(CC[C@@H]2[C@@]1(CCC3=C4CCC(=O)C=C4CC[C@@H]23)C)C
Properties
Molecular formula	C21H28O2
Molar mass	312.44582
Y (verify) (what is: Y/N?) Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa)
Infobox references

Demegestone is a progestogen.

Antiprogestin/
SPRM

antagonist: Mifepristone

Asoprisnil • CDB-4124  • Ulipristal acetate

Estrogens

Agonist	Steroidal Diosgenin • Estradiol (Ethinylestradiol#/Mestranol • Estradiol 17 beta-cypionate# • Polyestradiol phosphate) • Estrone (Estrone sulfate) • Estriol • Promestriene • Equilenin • Equilin Nonsteroidal Chlorotrianisene • Dienestrol • Fosfestrol • Diethylstilbestrol • Zeranol
Antiestrogen/ SERM	Afimoxifene • Arzoxifene • Bazedoxifene • Cyclofenil • Lasofoxifene • Ormeloxifene • Raloxifene • Tamoxifen • Toremifene Clomifene# • Mepitiostane • Nafoxidine pure antagonist: Fulvestrant
Aromatase inhibitors	nonselective: Aminoglutethimide • Testolactone selective: Anastrozole • Atamestane • Exemestane • Fadrozole • Formestane • Letrozole • Vorozole

^#WHO-EM. ^‡Withdrawn from market. Clinical trials: ^†Phase III. ^§Never to phase III

M: ♀ FRS anat/phys/devp noco/cong/npls, sysi/epon proc/asst, drug (G1/G2B/G3CD)